
    
      An international, multi-center, single-blind, randomized, active-controlled study with two
      parallel groups in patients with bacterial vaginosis. Eligible patients were randomized to
      receive Fluomizin vaginal tablets for 6 days or Clindamycin vaginal cream (2%) for 7 days.
      Control examinations were performed 3 to 14 days and 2 to 6 weeks after the end of the
      therapy.
    
  